Drug intelligence / Profile preview

CognatiQ

Development stage
Phase 1
Lead developer
FutureCeuticals
Modality
Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration
Oral
01

Overview

CognatiQ is a patented, clinically validated dietary supplement ingredient derived from the whole fruit of the Coffea arabica plant. It is standardized to contain at least 40% chlorogenic acids and minimal caffeine content. The key mechanism of action is its ability to significantly increase levels of brain-derived neurotrophic factor (BDNF), a neuroprotein essential for neurogenesis, synaptic plasticity, and overall cognitive function. Clinical studies have demonstrated that both acute (single dose) and chronic supplementation with CognatiQ can rapidly improve working memory, focus, accuracy, concentration, mental clarity, and information retention in healthy adults. These effects are attributed to its unique polyphenol profile—especially chlorogenic acid—which provides antioxidant and anti-inflammatory benefits while supporting neuronal health. Developed by FutureCeuticals using a sustainable process that utilizes the entire coffee fruit (skin, pulp, bean), CognatiQ is used as an ingredient in various cognitive health supplements and functional foods[1][2][3][4][5][6][7].

Brand names
CognatiQNeuroFactor
Other names
coffee fruit extractwhole coffee fruit extractCoffea arabica fruit extract
02

Targets

BDNF (Brain-derived neurotrophic factor)

Beyond the preview

Go deeper on CognatiQ.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CognatiQ.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call